Wholesale of pharmaceutical and medical goods
FARMACAN AS
Revenue 2024
NOK 889,000
Operating profit
NOK −290,000
Equity
NOK −265,000
Incorporated
2020
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 889k | |
| Total operating costs | 1.2m | |
| Operating profit (EBIT) | −290k | |
| Profit for the year | −290k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 525k | |
| of which current assets | 253k | |
| Equity | −265k | |
| Total liabilities | 790k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.